OptimizeRx Corporation

The momentum for this stock is not very good. OptimizeRx Corporation is not a good value stock. OptimizeRx Corporation is not a good growth stock. OptimizeRx Corporation is a mediocre stock to choose.
Log in to see more information.
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records,...
OPRX Fundamental Data by TradingView

News

OptimizeRx continues to expand strategic relationship with pharma client
OptimizeRx continues to expand strategic relationship with pharma client

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

Globe Newswire WALTHAM, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company ) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...\n more…

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

Globe Newswire The availability of Micro-Neighborhood Targeting on the Company's Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing...\n more…

Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround
Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround

Zacks Investment Research OptimizeRx Corp. (OPRX) has been beaten down lately with too much selling pressure. While the stock has lost 12.5% over the past four weeks, there is light at the end of the tunnel as it is now in...\n more…

OptimizeRx (NASDAQ:OPRX) & Eqonex (NASDAQ:EQOS) Critical Comparison
OptimizeRx (NASDAQ:OPRX) & Eqonex (NASDAQ:EQOS) Critical Comparison

Ticker Report OptimizeRx (NASDAQ:OPRX - Get Free Report) and Eqonex (NASDAQ:EQOS - Get Free Report) are both computer and technology companies, but which is the superior investment? We will compare the two...\n more…

OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00

Ticker Report OptimizeRx (NASDAQ:OPRX - Get Free Report) had its price target dropped by Royal Bank of Canada from $17.00 to $14.00 in a research report issued on Friday, Benzinga reports. The brokerage currently...\n more…